Abstract
With the increasing application of immune checkpoint inhibitors (ICIs) in tumor immunotherapy, the side effects on the immune system, known as immune-related adverse reactions (irAEs), also pose a key challenge to the clinical use of ICIs. Prior to this study, there was yet to be a comprehensive and systematic analysis of the relationship between ICIs, psychiatric complications and their influencing factors.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Annals of oncology : official journal of the European Society for Medical Oncology
Paper Title
Journal
Date
